SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 70.10
-0.20 (-0.28%)
At close: Mar 6, 2026
SciVision Biotech Revenue
In the year 2025, SciVision Biotech had annual revenue of 886.62M TWD with 0.37% growth. SciVision Biotech had revenue of 251.39M in the quarter ending December 31, 2025, a decrease of -1.49%.
Revenue
886.62M
Revenue Growth
+0.37%
P/S Ratio
5.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.62M | 3.31M | 0.37% |
| Dec 31, 2024 | 883.31M | 170.32M | 23.89% |
| Dec 31, 2023 | 712.99M | 155.64M | 27.93% |
| Dec 31, 2022 | 557.35M | 51.81M | 10.25% |
| Dec 31, 2021 | 505.54M | 38.66M | 8.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| St.Shine Optical | 4.40B |
| Visco Vision | 4.22B |
| Formosa Optical Technology | 3.98B |
| Vizionfocus | 3.30B |
| Pacific Hospital Supply | 2.47B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.07B |
| Bionime | 1.91B |